FDA declines to approve Eli Lilly's bowel disease drug

[cafead]

via Eli Lilly and Co said on Thursday that the U.S. Food and Drug Administration (FDA) had declined to approve its drug to treat a type of chronic inflammatory bowel disease in adults.

article source